Cary Street Partners’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99M Buy
47,191
+918
+2% +$38.7K 0.04% 382
2026
Q2
$1.9M Sell
46,273
-302
-0.6% -$11.9K 0.04% 376
2026
Q1
$1.66M Sell
46,575
-4,808
-9% -$180K 0.04% 353
2025
Q4
$1.96M Sell
51,383
-488
-0.9% -$18.7K 0.05% 332
2025
Q3
$1.96M Sell
51,871
-220
-0.4% -$8.04K 0.05% 323
2025
Q2
$1.84M Sell
52,091
-2,050
-4% -$67.2K 0.05% 320
2025
Q1
$1.75M Buy
54,141
+1,900
+4% +$63.7K 0.06% 306
2024
Q4
$1.74M Hold
52,241
– – 0.06% 297

Other funds holding TCAF

Cary Street Partners's TCAF Position: Q3 2026 in Review

Cary Street Partners increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 2% in Q3 2026, buying an estimated $38.7K and bringing the position to 47,191 shares worth $1.99M. The position accounts for 0.04% of the portfolio, ranked #382.

Cary Street Partners first reported a position in TCAF in Q4 2024 and has held it in 8 quarters since. 370 funds tracked by Wall St. Rank hold TCAF as of Q3 2026.

  • Cary Street Partners held 47,191 shares of T. Rowe Price Capital Appreciation Equity ETF worth $1.99M as of Q3 2026.
  • Cary Street Partners bought 918 T. Rowe Price Capital Appreciation Equity ETF shares in Q3 2026, an estimated $38.7K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.04% of Cary Street Partners's portfolio in Q3 2026, its #382 holding.
  • Cary Street Partners first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2024 and has held it in 8 quarters since.
  • 370 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q3 2026.

Based on Cary Street Partners's 13F filing for Q3 2026, filed 12 Nov 2026.